Rafferty Asset Management
OLMA icon

Rafferty Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Rafferty Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$945K Sell
75,522
-55,998
-43% -$750K ﹤0.01% 795
2026
Q1 		$1.96M Buy
131,520
+86,515
+192% +$1.93M 0.01% 616
2025
Q4 		$1.13M Buy
+45,005
New +$801K ﹤0.01% 774
2025
Q1 		– Sell
-81,424
Closed -$475K – 1128
2024
Q4 		$475K Sell
81,424
-9,051
-10% -$90.4K ﹤0.01% 923
2024
Q3 		$1.08M Sell
90,475
-11,531
-11% -$147K ﹤0.01% 785
2024
Q2 		$1.1M Sell
102,006
-192,713
-65% -$2.09M ﹤0.01% 794
2024
Q1 		$3.34M Buy
+294,719
New +$3.8M 0.01% 552

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Rafferty Asset Management's OLMA Position: Q2 2026 in Review

Rafferty Asset Management reduced its Olema Pharmaceuticals (OLMA) stake by 43% in Q2 2026, selling an estimated $750K and leaving 75,522 shares worth $945K. The position accounts for ﹤0.01% of the portfolio, ranked #795.

Rafferty Asset Management first reported a position in OLMA in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.34M in Q1 2024. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Rafferty Asset Management held 75,522 shares of Olema Pharmaceuticals worth $945K as of Q2 2026.
  • Rafferty Asset Management sold 55,998 Olema Pharmaceuticals shares in Q2 2026, an estimated $750K.
  • Olema Pharmaceuticals made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #795 holding.
  • Rafferty Asset Management first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Rafferty Asset Management's Olema Pharmaceuticals position peaked at $3.34M in Q1 2024.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.